MYC and plasma cell myeloma: More recently, Rajagopalan et al. [51] generated a NrasLSL Q61R/+ mouse which takes advantage of crossing Vk*MYC mice to mice harboring a Q61R NRAS mutation (as found in WGS studies of myeloma)[35,42,46].